Drug Type Chemical drugs |
Synonyms HXHTT024 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Dysmenorrhea | Phase 1 | China | - | 09 Mar 2026 |
| Fibroma | Phase 1 | China | - | 09 Mar 2026 |
| Hemorrhage | Phase 1 | China | - | 09 Mar 2026 |
| Menstruation Disturbances | Phase 1 | China | - | 09 Mar 2026 |
| Premenstrual Syndrome | Phase 1 | China | - | 09 Mar 2026 |
| Progesterone Deficiency | Phase 1 | China | - | 09 Mar 2026 |
| Pregnancy | IND Approval | China | 20 Jan 2025 |





